Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0076
-0.0004 (-5.00%)
Aug 19, 2026, 3:54 PM EST
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $2.63M in the quarter ending June 30, 2026, a decrease of -45.43%. This brings the company's revenue in the last twelve months to $18.05M, up 4.49% year-over-year. In the year 2025, Evofem Biosciences had annual revenue of $20.18M with 4.23% growth.
Revenue (ttm)
18.05M
Revenue Growth
+4.49%
P/S Ratio
0.06
Revenue / Employee
622.24K
Employees
29
Market Cap
1.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.18M | 820.00K | 4.23% |
| Dec 31, 2024 | 19.36M | 1.15M | 6.28% |
| Dec 31, 2023 | 18.22M | 1.38M | 8.20% |
| Dec 31, 2022 | 16.84M | 8.59M | 104.23% |
| Dec 31, 2021 | 8.24M | 7.80M | 1,748.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Evofem Biosciences News
- 5 days ago - Evofem Biosciences Quarterly report: Q2 2026 - Filings
- 5 days ago - Evofem Biosciences Earnings release: Q2 2026 - Filings
- 27 days ago - Evofem reports shipment of 500,000th box of PHEXX - TheFly
- 4 weeks ago - Evofem Biosciences Slides: Investor presentation - Filings
- 3 months ago - Evofem reports Q1 EPS (4c) vs. 0c last year - TheFly
- 3 months ago - Evofem Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Evofem Biosciences Quarterly report: Q1 2026 - Filings
- 3 months ago - Evofem Biosciences Earnings release: Q1 2026 - Filings